These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 19044179

  • 1. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a review. III. Angiotensin-converting enzyme inhibitors.
    Ascenção R, Fortuna P, Reis I, Carneiro AV.
    Rev Port Cardiol; 2008 Sep; 27(9):1169-87. PubMed ID: 19044179
    [Abstract] [Full Text] [Related]

  • 2. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S.
    Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
    [Abstract] [Full Text] [Related]

  • 3. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
    Weir R, McMurray JJ.
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
    [Abstract] [Full Text] [Related]

  • 4. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 5. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA, Molnar J, Arora RR.
    Diabetes Obes Metab; 2008 Jan 20; 10(1):41-52. PubMed ID: 18095949
    [Abstract] [Full Text] [Related]

  • 6. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S, Manchanda SC.
    Indian Heart J; 2003 Jan 20; 55(2):167-71. PubMed ID: 12921333
    [Abstract] [Full Text] [Related]

  • 7. Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.
    Gradman AH, Papademetriou V.
    Am Heart J; 2009 Jun 20; 157(6 Suppl):S17-23. PubMed ID: 19450720
    [Abstract] [Full Text] [Related]

  • 8. Effect of angiotensin-converting enzyme inhibitors in left ventricular dysfunction: results of the studies of left ventricular dysfunction in the context of other similar trials.
    Yusuf S, Garg R, McConachie D.
    J Cardiovasc Pharmacol; 1993 Jun 20; 22 Suppl 9():S28-35. PubMed ID: 7514238
    [Abstract] [Full Text] [Related]

  • 9. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX, Ye X, Lee KY, Dupclay L, Plauschinat C.
    Clin Ther; 2008 Jun 20; 30 Pt 2():2217-27. PubMed ID: 19281916
    [Abstract] [Full Text] [Related]

  • 10. Cross-sectional study of heart failure therapy with angiotensin converting enzyme inhibitors and digoxin.
    Mahmood SA, Hussein GM, Hamza EA.
    Saudi Med J; 2004 Aug 20; 25(8):1060-5. PubMed ID: 15322598
    [Abstract] [Full Text] [Related]

  • 11. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS, Bredikis A, Habib G, Carabello BA, Ramasubbu K, Bozkurt B.
    Am J Cardiol; 2008 Nov 15; 102(10):1356-60. PubMed ID: 18993155
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W.
    J Cardiovasc Electrophysiol; 2009 Apr 15; 20(4):395-400. PubMed ID: 19017351
    [Abstract] [Full Text] [Related]

  • 13. [Therapy of heart failure with ACE inhibitors--"evidence-based medicine" and clinical reality].
    Auer J, Berent R, Kirchgatterer A, Weber T, Mayr H, Maurer E, Eber B.
    Wien Med Wochenschr; 1999 Apr 15; 149(21-22):587-92. PubMed ID: 10666823
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG.
    J Indian Med Assoc; 2009 Mar 15; 107(3):178-82. PubMed ID: 19810392
    [Abstract] [Full Text] [Related]

  • 15. Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year.
    Houpe D, Peltier M, Cohen-Solal A, Béguin M, Lévy F, Slama M, Chapelain K, Tribouilloy C.
    Int J Cardiol; 2005 Sep 01; 103(3):286-92. PubMed ID: 16098391
    [Abstract] [Full Text] [Related]

  • 16. Management of hypertension in chronic heart failure.
    Manickavasagam S, Merla R, Koerner MM, Fujise K, Kunapuli S, Rosanio S, Barbagelata A.
    Expert Rev Cardiovasc Ther; 2009 Apr 01; 7(4):423-33. PubMed ID: 19379066
    [Abstract] [Full Text] [Related]

  • 17. Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction--a meta-analysis.
    Abdulla J, Pogue J, Abildstrøm SZ, Køber L, Christensen E, Pfeffer MA, Yusuf S, Torp-Pedersen C.
    Eur J Heart Fail; 2006 Jan 01; 8(1):90-6. PubMed ID: 16054435
    [Abstract] [Full Text] [Related]

  • 18. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM, Sanoski CA, Spinler SA.
    Pharmacotherapy; 2009 Jan 01; 29(1):31-48. PubMed ID: 19113795
    [Abstract] [Full Text] [Related]

  • 19. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease.
    Vonder Muhll I, Liu P, Webb G.
    Int J Cardiol; 2004 Dec 01; 97 Suppl 1():25-33. PubMed ID: 15590076
    [Abstract] [Full Text] [Related]

  • 20. [Revised insights and therapeutic goals in the treatment of chronic heart failure].
    van Veldhuisen DJ.
    Ned Tijdschr Geneeskd; 1999 Jul 17; 143(29):1507-11. PubMed ID: 10443272
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.